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Toll-Like Receptor 4 Has an Essential Role in Early
Skin Wound Healing
Lin Chen1, Shujuan Guo1, Matthew J. Ranzer1 and Luisa A. DiPietro1
Toll-like receptor 4 (TLR4) has a key role in the initiation of innate immunity and in the regulation of
adaptive immune responses. Using microarray analysis and PCR, TLR4 expression was observed to increase in
murine skin wounds at the early stages. The cellular location of TLR4 was primarily in keratinocytes at the
wound edges. The closure of excisional wounds was significantly delayed in TLR4-deficient (C3H/HeJ) as
compared with wild-type mice, and both IL-1b and IL-6 production were significantly lower in the wounds
of TLR4-deficient mice. EGF also markedly decreased in the wound edge of epidermis in TLR4-deficient mice.
In vitro studies confirmed that a wound stimulus induces TLR4 mRNA expression in primary normal human
epidermal keratinocytes (NHEK). In vitro injury also induced the phosphorylation of p38 and JNK MAPK (Jun
N-terminal kinase mitogen-activated protein kinase) and the expression of IL-1b and tumor necrosis factor-a by
NHEK. Blockade of TLR4 delayed NHEK migration and abolished the phosphorylation of p38 and JNK MAPK, and
blockade of TLR4 and/or p38/JNK abolished IL-1b production. The results suggest that inflammatory cytokine
production by injured NHEK is stimulated via the TLR4-p38 and JNK MAPK signaling pathway. Together, the
results provide evidence for a role of TLR4 at sites of injury, and suggest that TLR4 is an important regulator of
wound inflammation.
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INTRODUCTION
Skin wound healing is a dynamic pathophysiological process
orchestrated by complicated interactions of extracellular
matrix molecules, growth factors/cytokines, and various
resident cells, including keratinocytes, fibroblasts, and
infiltrating leukocytes. The innate immune response in the
skin serves not only to eliminate infections following injury
but also to maintain homeostasis and functional integrity, and
may be active in restoring structure to damaged tissues
(Martin, 1997; Saltzman, 1999; Frantz et al., 2005).
Toll-like receptors (TLRs) have a key role in host defense
by regulating both innate and adaptive immune responses
(Takeda and Akira, 2005). They recognize multiple pathogen-
associated molecular patterns, such as lipopolysaccharide
(LPS) via TLR4, and lipopeptides and lipoproteins via
TLR2 (Takeda and Akira, 2005; Miller and Modlin, 2007).
Once a TLR is activated by its corresponding ligand,
downstream signaling molecules are activated, leading to
the nuclear translocation of transcription factor NF-kB and/or
activation of the mitogen-activated protein kinase (MAPK).
The MAPK family includes p38, and Jun N-terminal kinase
(JNK), which leads to the transcription of target inflammatory
cytokine genes (Akira and Takeda, 2004; Takeda and
Akira, 2005; Miller and Modlin, 2007). Ultimately, TLR
signaling pathways regulate gene expression profiles, includ-
ing the production of cytokines, upregulation of costimula-
tory molecules, and adhesion molecules (Akira and
Takeda, 2004; Takeda and Akira, 2005; Miller and Modlin,
2007).
Skin keratinocytes have been demonstrated to express
TLR1-6 and 9 (Song et al., 2002; Baker et al., 2003; Kollisch
et al., 2005; Lebre et al., 2007). Various TLRs have also been
identified to have a role in skin diseases such as psoriasis,
leprosy, and atopic dermatitis (Miller and Modlin, 2007).
Studies also suggest that TLR4 is involved in the response to a
variety of injuries. In an incisional wound-repair model,
TLR4-deficient mice demonstrated a significant decrease in
tumor necrosis factor-a (TNF-a) in the wound and increased
wound-breaking strength (Bettinger et al., 1994). In addition,
TLR4-deficient mice exposed to burn injury exhibited
increased immunosuppression (Jobin et al., 2000). Further-
more, enhanced TLR2 and TLR4 reactivity is important to the
production of IL-1b, IL-6, and TNF-a in the spleen following
severe burn injury in mice (Maung et al., 2005). Although a
role for TLR4 in the immune response to burn injury is well
studied, the role of TLR4 in the inflammatory response to
excisional wounds has not been well investigated.
In the present study, we investigated changes in the
expression of TLR4 and its downstream signaling molecules
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in response to injury both in vitro and in vivo. The results
suggest that TLR4 has an important role in the early
inflammatory response in wound healing and regulates
inflammatory cytokine production in injured keratinocytes
via the TLR4/p38 and JNK MAPK signaling pathways.
RESULTS
TLR4 is upregulated in the early phase of skin wound healing
To examine whether TLR4 expression is modulated by injury,
we analyzed the data from a previous microarray study (Chen
et al., 2010), which delineated the transcriptome of a 1-mm
excisional skin wound in BALB/c mice. The data showed that
TLR4 gene expression was significantly increased at 12 and
24 hours post wounding, and then gradually returned to
baseline by day 10 (Figure 1a). In addition, TLR4 mRNA
expression examined by PCR in 3-mm skin wounds of TLR4
wild-type mice had the same pattern as in the microarray
study (Figure 1b). These results demonstrate that TLR4 gene
expression is significantly increased at sites of skin injury. To
determine the cellular location of TLR4 expression in the
wounds, wound sections of wild-type mice were examined
using indirect immunofluorescence. As shown in Figure 1c,
normal skin exhibited nonspecific staining of the keratinized
layer. In wounds, including time points of 6 hours, 1 day and
3 days after wounding, TLR4 was clearly observed in all
layers of keratinocytes at the wound edge, including those at
the migrating tip (day 3). In addition, the expression was more
evident in the epidermal area slightly distant from the wound
edges than in the areas immediately next to the edges in both
6-hour and day 1 wounds. In contrast, very few cells within
the wounded dermis stained positively for TLR4. The intensity
of TLR4 expression in the keratinocytes at wound edges at
days 7 and 10 significantly decreased as the wound healing
progressed. As expected, no TLR4-positive staining was seen
in skin from TLR4-deficient mice (Figure 1c). The results
strongly suggest that TLR4 expression in skin wounds
localizes primarily to the epidermal keratinocyte compart-
ment in wild-type mice.
TLR4-deficient mice exhibit impaired early-stage skin wound
closure
From days 1–5 post wounding the wound areas of TLR4-
deficient mice were significantly larger than wild-type mice
(Po0.05, Figure 2a and b). However, by 10 days post
wounding, the wound sizes of the two groups of mice showed
no statistical difference (Figure 2a and b). Concordant with the
external analysis of wound healing, histological analysis
showed that the percent re-epithelialization in TLR4-deficient
mice was lower than that of wild-type mice with statistically
significant differences observed at days 3 and 7 (Figure 2c and
d). Furthermore, less Ki67-positive proliferating keratinocytes
were seen at the edges of wounds in TLR4-deficient mice at
days 1 and 3 than in wounds of wild-type mice (Figure 2e).
These data suggest that TLR4 has a prominent role in the early
stage of wound healing and specifically influences keratino-
cyte function. Interestingly, neither capillary density (Figure 2f)
nor collagen staining (Figure 2g) showed any significant
difference between these two groups of mice.
TLR4 mutation alters inflammatory cell infiltration and cytokine
expression in skin wounds
At day 7 post wounding, the number of neutrophils was
significantly higher in the wounds of TLR4-deficient mice
versus those of wild-type mice (Po0.01, Figure 3a).
Although a slight increase in neutrophils was observed in
the wounds of the deficient mice at multiple other time
points, the difference did not reach significance (P40.05,
Figure 3a). Macrophage content was significantly higher in
wounds of deficient mice than in wild-type mice at 6 hours
and 3 days post wounding (Po0.01 and o0.05, respec-
tively, Figure 3b). The pattern of T-cell infiltration also
differed in deficient and wild-type mice. Although the
number of CD3þ T cells in the wounds of wild-type mice
peaked at day 7 and started to decline at day 10, the number
of CD3þ cells continued to increase from day 7 to day 10
post wounding in the deficient mice. By day 10, the wounds
of deficient mice contained significantly more T cells than
did the wounds of wild-type mice (Po0.01, Figure 3c).
Taken together, the results suggest that the loss of a
functional TLR4 resulted in increased inflammatory cell
content in wounds at discrete time points during the healing
process.
Changes in the expression of several proinflammatory
cytokines were also observed in the TLR4-deficient mice.
IL-1b expression levels were significantly reduced in the
wounds of deficient versus wild-type mice 6 hours post
wounding (Figure 3d). The expression of IL-6 in the wounds
of deficient mice exhibited both decreased levels at 6 hours
after wounding as well as a shift in the time of peak
expression from 6hours to day 1 compared with wild-type
mice (Figure 3e). A significantly higher level of expression of
IL-6 in the wounds of TLR4-deficient mice persisted from day
1 to day 3 (Figure 3e). No significant changes were observed
between these two groups of mice for TNF-a expression
(Figure 3f). These results suggest that engagement of TLR4 is
involved in the modulation of the inflammatory cytokines
IL-1b and IL-6 in early skin wounds.
Using laser capture microdissection and reverse-tran-
scriptase–PCR, we further examined the mRNA expression of
these cytokines specifically in epithelial cells isolated from
the edge of the 6-hour wound. Compared with wild-type
mice, IL-1b was downregulated 7-fold (Po0.01), whereas IL-
6 was upregulated 2-fold in TLR4-deficient mice (Po0.01)
(Figure 3g). As IL-6 expression in the total wound tissue was
less in TLR4-deficient than wild-type mice, the data from
isolated epithelium suggest that TLR4-associated expression
patterns of IL-6 within the wound bed itself differ from that of
isolated wound edge epithelium. Interestingly, the laser
capture microdissection analysis also showed a 7-fold
decrease in EGF expression in the wound edge epithelium
from TLR4-deficient mice (Figure 3g) as compared with
control (Po0.01). No difference was observed in TNF-a
levels (Figure 3g). Interestingly, TLR2 expression was
significantly higher in wounds of TLR4-deficient mice than
wild-type mice at day 1 (Figure 3h), suggesting TLR4
deficiency results in compensatory expression of TLR2 post
wounding.
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Injury induces keratinocyte expression of IL-1b and TNF-a
through activation of TLR4 via p38/JNK MAP kinase
TLR4 mRNA was not detectable in normal human epidermal
keratinocytes (NHEK) under standard conditions. However,
after in vitro scratch injury, NHEK expressed detectable and
significant TLR4 mRNA from 1 to 3 hours post wounding
(Figure 4a). The level of TLR4 induced by wounding, while
demonstrable, was significantly less than the levels induced
by LPS treatment, a known robust stimulator of TLR4 in
keratinocytes (Po0.01). NHEK showed a temporal response
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Figure 1. Toll-like receptor 4 (TLR4) gene and protein expression are upregulated in early skin wounds. (a) Microarray analysis shows that all four TLR4 probes
in the array demonstrate a significant increase in expression, especially from 12hours to 1 day (Po1.2107, one-way analysis of variance (ANOVA)). (b) Real-
time PCR confirms that TLR4 mRNA is markedly increased in early-stage wounds in TLR4 wild-type mice (P¼ 0.0003, one-way ANOVA). N¼ 3 at each time
point. (c) Photomicrographs of indirect immunofluorescence detection of TLR4 in skin wounds of TLR4-deficient and wild-type mice. The control (rabbit IgG
staining) histologic sections of wounds from TLR4-deficient mice, as well as the 6-hour wound sample from wild-type mice, were also stained with 4’-6-
diamidino-2-phenylindole (DAPI) (blue). White arrows indicate wound edges, red arrow indicates fibrin clot, yellow arrow indicates advancing epidermal tip,
and blue arrows show the higher magnification of the outlined areas. Bar¼ 200mm.
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to in vitro injury, with TLR4 mRNA levels returning to
undetectable by 8 hours post wounding (Figure 4a). To
evaluate the levels of TLR4 expression in NHEK, these results
were compared with TLR4 expression in LPS-treated or
untreated THP1, a cell type known to exhibit high levels of
TLR4. Although TLR4 expression in NHEK was several fold
lower than THP1 (Figure 4a, Po0.0001), the relative increase
upon LPS stimulation was much greater in NHEK as
compared with THP1 cells. This result suggests that TLR4
expression by wound keratinocytes may include responses to
stimuli beyond bacterial molecular patterns. mRNA expres-
sion of IL-1b and TNF-a was dramatically elevated at 3, 8 and
24 hours post wounding (Po0.05–0.01 vs. unwounded cells)
(Figure 4b). In vitro wounding also led to substantial
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Figure 2. Mice with a Toll-like receptor 4 (TLR4) mutation exhibit impaired early wound healing without vascularity changes. (a) Representative
photomicrographs of wounds at 0 and 6hours as well as 1, 3, 5, 7, and 10 days after injury. Bar¼ 3mm. (b) Percent of original wound size, N¼ 5, *Po0.01,
#Po0.05 versus wild type. (c) Photomicrographs of hematoxylin/eosin (HE)-stained histologic sections of wounds. Bar¼500 mm. (d) Rate of wound
re-epithelialization measured by histomorphometric analysis of tissue sections. N¼ 5, * Po0.01 versus wild type. (e) Photomicrograpahs of ki67þ (red)
proliferating keratinocytes with nuclear 4’-6-diamidino-2-phenylindole (DAPI) counterstaining (blue). Arrows indicate wound edges. Bar¼ 200mm. (f) Percent
area occupied by CD31-stained vessels at day 7 and 10 after wounding. N¼ 5 at each time point. (g) Photomicrographs of Masson’s trichrome-stained histologic
sections of day 10 wounds. Bar¼500 mm.
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production of IL-1b and TNF-a protein by injured keratino-
cytes (Figure 4c).
To investigate the role of TLR4 in the production of IL-1b
and TNF-a following injury, the activation of the TLR4
signaling pathway was examined. Nuclear translocation of
NF-kB was not observed at either 15minutes or 6 hours post
injury (Figure 5n and o). However, NHEK at the wound edge
exhibited phosphorylated p38 (p-p38) (Figure 5b), but not
p-JNK (Figure 5h) at 15minutes post injury. By 6hours post
wounding, a significant increase in p-p38 and p-JNK was
observed (Figure 5c and i). Levels of p-p38 and p-JNK
diminished to undetectable by 24 hours (data not shown).
Unwounded cells did not show any positive staining (Figure
5a and g). A direct link between TLR4 and p38/JNK
phosphorylation was also shown, as antibody neutralization
of TLR4 completely inhibited the phosphorylation of p38 and
JNK (Figure 5d and j), while non-specific IgG did not have
such an effect (Figure 5e and k). NHEK also displayed p38
phosphorylation in response to LPS treatment. Following LPS
treatment, p-p38 was observed by 15minutes and reached
peak levels at 30minutes. Levels of p-p38 decreased
dramatically with longer treatment times (1–24 hours) (data
not shown). LPS treatment did not result in phosphorylation
of JNK or nuclear translocation of NF-kB (data not shown).
The importance of TLR4 for keratinocyte migration and in
the production of IL-1b and TNF-a following in vitro injury
was explored using an antibody blockade strategy. When
compared with control, treatment with neutralizing anti-TLR4
antibody before injury resulted in a significant decrease in the
number of migrating cells (Figure 6a and b, Po0.05).
Blockade of TLR4 by anti-TLR4 antibody also abolished IL-
1b production (Figure 6c), suggesting that TLR4 activation is
requisite for IL-1b expression. Inhibition of p38 or JNK
inhibitor also resulted in a significant decrease in IL-1b
production (Figure 6c). Use of both p38 and JNK inhibitors, or
anti-TLR4, p38, and JNK inhibitors combined resulted in
IL-1b at levels similar to p38 inhibition alone (Figure 6c).
Overall, the induction of IL-1b production appeared to occur
through the TLR4 pathway via phosphorylation of p38 and
JNK, but not via NF-kB. In contrast to IL-b, anti-TLR4
treatment did not affect TNF-a production following in vitro
injury (Figure 6d). However, both p38 and JNK inhibitors
caused a significant reduction in TNF-a (Po0.01 ando0.05,
respectively), with the effect of the p38 inhibitor being
considerably greater (Po0.01) (Figure 6d). The results suggest
that for the induction of TNF-a, molecules other than TLR4 lie
upstream of p38 and JNK.
DISCUSSION
The current investigation demonstrates that TLR4 gene
expression is modulated over the time course of healing. A
functional role for TLR4 in wound healing was shown as
wound closure was significantly impaired in TLR4-deficient
mice. TLR4-deficient mice also exhibited changes in the
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Figure 3. Wounds of Toll-like receptor 4 (TLR4)-deficient and wild-type mice show differences in inflammatory cell and cytokine content. (a–c) The number
of neutrophils, macrophages, and CD3þ T cells, respectively, in the wounds, determined by immunohistochemistry. (d–f, h) mRNA levels of IL-1b, IL-6,
tumor necrosis factor-a (TNF-a) and TLR2 in wounds, as determined by real-time PCR. *Po0.01, #Po0.05, N¼ 5 at each time point. Expression in the normal
skin of wild-type mice was used as baseline. (g) mRNA levels of IL-1b, IL-6, TNF-a, and EGF in epithelial cells at the 6-hour wound edges determined by laser
capture microdissection (LCM) and reverse-transcriptase–PCR (RT–PCR). Data are averages of triplicate wells, and are representative of two independent
experiments. *Po0.01 versus wild type.
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levels of IL-1b, IL-6, and EGF, as well as altered infiltration of
neutrophils, macrophages, and T cells in the wounds.
Together with the current evidence that TLR4 expression
localizes primarily to keratinocytes at the wound edge rather
than cells in the dermis, our results suggest that TLR4
engagement by keratinocytes is critical to the inflammatory
response in skin wounds and that TLR4-positive keratinocytes
have a significant role in the healing response.
Keratinocytes provide an important physical barrier
between the external and internal environments. The
production of cytokines by keratinocytes influences kerati-
nocyte proliferation and differentiation processes, enhances
the recruitment of inflammatory cells, and may have
systemic effects on the immune system (Uchi et al., 2000;
Grone, 2002). Keratinocytes at the edge of the wound of
TLR4-deficient mice exhibited a noticeably lower level of
EGF, a growth factor that can substantially affect proliferation
and migration of keratinocytes (Rheinwald and Green, 1977;
Dvir et al., 1991; Chen et al., 1993). This result may provide
an explanation for the reduction in proliferating keratinocytes
in the wounds of TLR4-deficient mice. A decrease in epithelial
proliferation in TLR4-deficient mice is consistent with the
findings that TLR4-deficient mice had larger wounds and
delayed re-epithelialization compared with wild-type mice.
The current studies describe a particular signaling pathway
in keratinocytes by which TLR4 promotes the initial
inflammatory response to injury in vitro. Our studies suggest
that the expression and activation of TLR4 in injured
keratinocytes leads to phosphorylation of p38 and JNK,
followed by the production of IL-1b. Our studies demonstrate
that the production of IL-1b by injured keratinocytes occurs
primarily through the TLR4-p38/JNK pathway rather than the
TLR4-NF-kB pathway. Interestingly, the activation of TLR4
did not appear to be linked to injury-induced TNF-a produc-
tion, suggesting that other pathways induce TNF-a produc-
tion by keratinocytes following wounding. One receptor
complex which might also have a role in the post-injury
response is the inflammasome, a protein complex whose
major components consist of NLRs including NODs (nucleo-
tide-binding oligomerization domain-1), NALPs (NACHT-, LRR-
and pyrin-domain-containing proteins), IPAF (ICE-protease
activating factor), NAIPs (neuronal apoptosis inhibitor fac-
tors), and CIITA. Activation of the inflammsome, which is a
recently identified complex of intracellular pathogen-recog-
nition receptors (Martinon and Tschopp, 2005; Becker and
O’Neill, 2007) results in activation of caspase-1, which
cleaves pro-IL-1b to produce mature IL-1b (Martinon and
Tschopp, 2005; Becker and O’Neill, 2007). Interactions
between TLRs and NLRs have also been reported (Martinon
and Tschopp, 2005; Becker and O’Neill, 2007). As our study
suggests that injured keratinocytes produce IL-1b through
TLR4 activation, and the inflammasome has previously been
detected in keratinocytes (Watanabe et al., 2007), it seems
likely that the inflammasome is also involved in responses
described here. A role for the inflammasome in inflammation
associated with injury has been proposed (McDonald et al.,
2010), and this topic will require additional investigation.
TLRs not only recognize pathogen-associated molecular
patterns, they also detect endogenous danger signals, or
damage-associated molecular patterns, that are released by
stressed and injured tissues or cells. Numerous recent
reports have demonstrated that damage-associated
molecular patterns, such as hyaluronanic acid (Termeer
et al., 2002; Taylor et al., 2004), heparan sulfate (Johnson
et al., 2002), fibrinogen (Smiley et al., 2001), surfactant
protein-A (Okamura et al., 2001), high-mobility group box 1
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(Wang et al., 1999; Park et al., 2004, 2006), b-defensin
(Biragyn et al., 2002), and heat-shock proteins (Ohashi et al.,
2000; Asea et al., 2002; Dybdahl et al., 2002; Vabulas et al.,
2002), interact with TLR4 and induce the production of
inflammatory cytokines. Although we have not yet investi-
gated the specific ligands that interact with TLR4 in the
context of the wound, the identification of these endogenous
ligands from stressed or injured tissues by TLR4 may have
important pathophysiological implications in wound healing.
The current study would suggest that following injury, local
mechanical damage leads to a rapid and significant increase
in TLR4 expression. One important caveat is that inflamma-
tory patterns in wounds are complex, and most certainly
modulated by many ligands beyond TLR4. Such complexity
may explain the observation of decreased levels of IL-1b and
IL-6 in the early wounds of TLR4-deficient mice yet increased
inflammatory cell infiltration at discrete time points. One
possible explanation relates to alternative activation of other
TLRs such as TLR2 when TLR4 does not function. Indeed,
TLR2 expression was significantly increased post wounding
in TLR4-deficient mice. Complicated patterns of cytokine
expression also appear to be involved. More specifically, IL-6
expression in the wounds of TLR4-deficient mice exhibited a
pattern that included an early decrease but sustained levels
above that of wild type at several time points beyond day 1.
This sustained level of IL-6 may contribute to altered healing
outcomes, as prior studies suggest that IL-6 is important to
normal wound closure yet may promote scar formation
(Gallucci et al., 2000; Dasu et al., 2004; Ghazizadeh et al.,
2007). Overall, the changes in IL-6 expression seen in the
wounds of TLR4-deficient mice might impact healing in
many ways.
Our findings show that the wounds of TLR4-deficient mice
heal more slowly, and that in the absence of functional TLR4,
the number of inflammatory cells in the wound was slightly
increased. Although the increase was subtle, this finding is in
keeping with the general notion that excessive cellular
inflammation can be detrimental to repair (Martin and
Leibovich, 2005). Indeed, some wounds that heal extremely
well, including fetal skin and mucosa, exhibit little or no
inflammation (Longaker et al., 1990; Szpaderska et al., 2003).
However, in adult skin the situation is complex and there
appears to be a fine line between ‘‘good’’ inflammation and
‘‘bad’’ inflammation as it pertains to repair. TLR4 may have a
role in the innate immune system of skin, which subtly harnesses
inflammation, so that wounds heal favorably with resistance
to infection, and with appropriate restoration of structure.
Pertinent to the current study is the finding that incisional
wounds of TLR4-deficient mice show a significant increase in
wound-breaking strength (Bettinger et al., 1994). A recent
study also suggests that TLR4 may have a role in the fibrotic
response in skin wounds (Wang et al., 2011). Although we
did not see significant changes in collagen content in TLR4-
deficient mice, we did not quantify the wound collagen
architecture for characteristics that are important to wound
strength or that signify wound fibrosis. Thus, the question of
whether TLR4 signaling influences the fibrotic response in
skin wounds remains open.
In summary, our results demonstrate that (1) TLR4 is
upregulated and activated in early skin wound healing; (2) a
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Figure 5. Scratch wound injury induces expression of p-p38 and p-JNK MAPK, but not NF-jB nuclear translocation in normal human epidermal keratinocytes
(NHEK). Nuclear NF-kB, p-p38, and p-JNK were detected using immunofluorescence 15minutes and 6hours after wounding. To test the effects of anti-Toll-like
receptor 4 (TLR4) antibody on induction of p-p38 (red) and p-JNK (green), NHEK were treated with anti-TLR4 or mouse IgG before scratch injury. (a, g, m)
Unwounded NHEK; (b, h, and n) 15minutes after injury; (c–e, i–k) 6 hours after injury; (p) tumor necrosis factor-a (TNF-a)–treated NHEK as NF-kB–positive
control; (f, l) anisomycin-treated NHEK as positive control for p-p38 and p-JNK; (a, d, g, h, j, m) were also stained by 4’-6-diamidino-2-phenylindole (DAPI)
(blue). UW, unwounded. Arrows indicate wound edges. Bar¼ 100mm.
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functional mutation of TLR4 results in altered inflammatory
cell infiltration, differential cytokine production, and im-
paired wound closure; and (3) IL-1b production by injured
keratinocytes is induced through the TLR4-p38/JNK pathway.
The results provide previously unreported evidence that TLR4
is a critical regulator in wound inflammation, and that this
receptor supports the creation of an optimal early inflamma-
tory environment in healing skin.
MATERIALS AND METHODS
Wound model
Six–eight-weeks-old C3H/Hej TLR4-deficient and wild-type C3H/
HeOuj mice (Jackson Laboratory, Bar Harbor, ME) were used in the
study. C3H/Hej mice have a mutation in the third exon of the TLR4
gene. A C to A substitution at nucleotide position 2342 results in an
amino-acid substitution that replaces proline with histidine at position
712; this mutation renders the molecule non-functional (Poltorak
et al., 1998; Hoshino et al., 1999). Six full-thickness dermal excisional
wounds were placed on opposite sides of the midline using a 3-mm
punch biopsy instrument. Wounds and surrounding tissues were
harvested using 5- and 3-mm biopsy punches for samples at 6 hours
and day 1 and samples at days 3, 5, 7, and 10, respectively. The
wounds were also photographed at the time points indicated above
and the wound sizes were determined by software AxioVision (ZEISS,
Oberkochen, Germany). The microarray analysis was performed as
previously described (Chen et al., 2010). The procedures for making
and harvesting wounds were the same as for the 3-mm wound model
described above. All animal procedures were approved by the
University of Illinois Institutional Animal Care and Use Committee.
Examination of re-epithelialization and collagen
Hematoxylin/eosin and Masson’s Trichrome staining were performed
according to the manufacturer’s instructions (Sigma, St Louis, MO).
The extent of re-epithelialization was measured by histomorpho-
metric analysis of the hematoxylin/eosin-stained wounds as de-
scribed previously (Schrementi et al., 2008).
Cell culture and in vitro wound injury
NHEK (ATCC, Manassas, VA) were cultured in two-chamber slides
to 80% confluence. Injury was produced by the application of nine
horizontal and nine vertical scratch wounds using 1-ml pipette tips.
In some experiments, cells were treated with mouse anti-human
TLR4 or mouse IgG (eBioscience, San Diego, CA) for 90minutes
before injury. NHEK and THP1 (human acute monocytic leukemia
cell line, 1 105, ATCC) treated with LPS (100 ngml–1, Sigma) for
indicated times were used as positive controls for TLR4 expression
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Figure 6. Neutralization of Toll-like receptor 4 (TLR4) delays normal human epidermal keratinocyte (NHEK) migration and abolishes IL-1b production in
injured NHEK. (a, b) NHEK monolayers were pretreated with anti-TLR4 or normal mouse IgG (20mgml–1) followed by mitomycin C (10 mgml–1) treatment, and
then wounded by scratches. The defined areas were photographed at 0 and 16 hours after wounding. The numbers of cells migrated out of the initial areas were
counted. N¼ 4. *Po0.05 compared with IgG control. (c, d) Cultured NHEK were incubated with anti-TLR4 and/or p38 inhibitor SB203580, and/or Jun N-
terminal kinase (JNK) inhibitor SP600125, and then cells were injured by scratching. The supernatants were collected 24 hours later for IL-1b and tumor necrosis
factor-a (TNF-a) ELISA analyses. N¼3, *Po0.01, #Po0.05 compared with wounded untreated cells. UW, unwounded. Bar¼100 mm.
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after injury. At 1, 3, 8, and 24 hours after injury or LPS treatment,
total RNA was extracted using Trizol (Invitrogen, Carlsbad, CA). At
15minutes and 6 hours after injury, samples were examined for the
nuclear translocation of NF-kB and p-p38/p-JNK using immuno-
fluorescence. Anisomycin (25 mgml–1, Sigma), a kinase activator,
was used to treat NHEK for 30minutes, which served as a positive
control to detect p-p38/JNK. To examine the role of TLR4 and its
signaling pathway in the production of IL-1b and TNF-a, cells were
incubated with anti-TLR4 antibody (20 mgml–1) and/or p38 inhibitor
SB203580 (5mM), and/or JNK inhibitor SP600125 (0.15 mM) (both
from LC Laboratories, Woburn, MA) for 90minutes before injury.
Twenty-four hours after injury, supernatants were collected for
detection of protein levels of cytokines by ELISA. All in vitro cell
culture experiments were performed in the presence of 10 mgml–1
polymyxin B (Sigma) to exclude the effects of any LPS contamination
(Horton et al., 1998; Jiang et al., 2005). For in vitro migration assay,
confluent NHEK were treated with mitomycin C (10 mgml–1, Sigma)
for 2 hours to prevent cell proliferation and then incubated with anti-
TLR4 or IgG (20 mgml–1) for 90minutes followed by scratch
wounding. The defined areas were photographed at 0 and 16 hours
after wounding and the number of cells that had migrated out of the
initial wound area were counted.
Real-time PCR, laser capture microdissection, cytokine ELISA,
detection of TLR4, CD3þ T cells, neutrophils, macrophages,
proliferating cells (Ki67), NF-jB, p-p38, and p-JNK by
immunohistochemistry
See details in Supplementary Materials and Methods online.
Statistical analyses
Data are expressed as meanþ SD. The Student’s t-test was used to
compare the difference between TLR4-deficient and wild-type mice
at each time point. One-way analysis of variance test was used
to identify significance in some experiments. P values o0.05 were
considered significant.
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